Rigel Pharmaceuticals Inc (RIGL): Weighted Average Diluted Shares
18.84M
Year ended 2025-12-31
+3.4%
3-year compound annual growth
| Period ended | Weighted Average Diluted Shares | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | 18.84M | +6.5% | 2026-03-03, From 2025-01-01 |
| 2024-12-31 | 17.69M | +1.6% | 2026-03-03, From 2024-01-01 |
| 2023-12-31 | 17.40M | +2.1% | 2026-03-03, From 2023-01-01 |
| 2022-12-31 | 17.05M | n/c | 2025-03-04, From 2022-01-01 |
| 2021-12-31 | 170.49M | +1.0% | 2024-03-05, From 2021-01-01 |
| 2020-12-31 | 168.75M | +0.8% | 2023-03-07, From 2020-01-01 |
| 2019-12-31 | 167.40M | n/c | 2022-03-01, From 2019-01-01 |
| No annual figure between 2014-12-31 and 2019-12-31. | |||
| 2014-12-31 | 87.66M | +0.4% | 2015-03-03, From 2014-01-01 |
| 2013-12-31 | 87.29M | +16.4% | 2015-03-03, From 2013-01-01 |
| 2012-12-31 | 74.97M | +18.4% | 2015-03-03, From 2012-01-01 |
| 2011-12-31 | 63.33M | +20.5% | 2014-03-04, From 2011-01-01 |
| 2010-12-31 | 52.57M | +28.6% | 2013-03-05, From 2010-01-01 |
| 2009-12-31 | 40.88M | n/a | 2012-03-06, From 2009-01-01 |